Logged in - Premium content - no access | Access control messages | Drug Target Review

Skip to main content
Skip to navigation

Sorry – this content is exclusive to premium members.

But there’s still so much great content to discover.

Topics

Neurological disorders

Related articles

News
Cerebral organoids identify Ebola virus persistence in neural tissue

2026-06-23T09:12:00Z

By Drug Target Review
News
Thalidomide shows potential for treating rare brain vascular malformations

2026-06-22T13:04:00Z

By Drug Target Review
News
AI-powered $6M project targets new Alzheimer’s treatments

2026-06-16T12:47:00Z

By Drug Target Review
News
Copper drug Cu(ATSM) reduces Alzheimer’s proteins by 42 percent in preclinical study

2026-06-15T12:35:00Z
News
Cytokine-armoured CAR T cells target glioblastoma while reducing treatment toxicity

2026-06-12T11:50:00Z

By Drug Target Review
News
Study suggests senolytic therapies could slow spinal disc degeneration

2026-06-05T09:00:00Z

By Drug Target Review

Partner content

Article
Women in STEM: resilience and leadership in rare disease research

2026-05-19T09:46:00

Contributor Dr Nitza Thomasson
Webinar
The truth about AI in drug discovery: what the experts really think

2026-03-11T14:00:00

Sponsored by Merck
Webinar
What it takes to automate high-content imaging at scale

2026-03-25T15:00:00

Sponsored by Yokogawa
Whitepaper
ebook: Fluorescence polarization assays

2023-06-30T14:20:35

Sponsored by BPS Bioscience
Webinar
Manufacturing the Future: from N=1 personalised CRISPR therapy to scalable precision genomic medicine

2026-06-02T15:00:00

Sponsored by Danaher Life Sciences
Video
Webinar: Accurate detection of mitochondrial toxicity

2023-03-07T10:55:58

Sponsored by Agilent